Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 4

Review

Bendamustine HCL for the treatment of relapsed indolent non-Hodgkin’s lymphoma

       
Total article views   HTML views PDF downloads Totals
6,058 Dovepress* 6,058+ 2,334 8,392
Totals 6,058 2,334 8,392
*Since 8 August 2008
+Since July 2016

View citations on Google Scholar